Sreeja Biswas

Premium

Healthcare

26 September, 2024

Phi Capital-backed Krsnaa Diagnostics buys into healthcare startup

Krsnaa Diagnostics Ltd, which operates radiology and pathology centres through an asset-light model, has signed a deal to acquire a ......

Premium

General

26 September, 2024

Grapevine: TPG-backed OneSource eyes funding; Nomura, Mizuho lead race for Avendus

OneSource, a specialty pharma contract development and manufacturing firm backed by TPG Growth, is in talks with investors, including White Oak ......

Premium

Consumer

25 September, 2024

Searchlight: Jell Pharma's revenue breaks out of a range, but is it sustainable?

Mumbai-based health and beauty products manufacturer Jell Pharmaceuticals Pvt Ltd. has returned to double-digit revenue growth for the year ending March ......

Premium

General

25 September, 2024

Grapevine: Swiggy, Hyundai, InCred in IPO news; Jupiter eyes SBM India

Swiggy has secured approval from Securities and Exchange Board of India (SEBI) for its initial public offering (IPO) of shares ......

Healthcare

24 September, 2024

VC-backed Redcliffe Labs eyes second acquisition of the year

Healthtech platform Redcliffe Lifetech Pvt Ltd, which operates diagnostic centres under the Redcliffe Labs brand, is set to mark its second acquisition ......

Premium

General

24 September, 2024

Grapevine: Edelweiss Alts' Sekura buys 350 MW project; Pratilipi eyes IPO

Sekura Energy, the energy platform of Edelweiss Alternatives, has acquired 350 MW of operational assets from O2 Power in Madhya Pradesh, ......

Premium

Consumer

23 September, 2024

Why diaper maker Uniclan was valued at half its revenue in strategic buyout

Uniclan Healthcare Pvt Ltd, the maker of baby diapers under the Wowper brand, has found a new majority owner in ......

Premium

Healthcare

23 September, 2024

Core Diagnostics gets buyout interests as Eight Roads seeks exit

Venture Capital-backed Core Diagnostics Pvt Ltd, which offers specialised diagnostic services, has received acquisition offers from strategic investors looking to buy ......

Premium

Healthcare

23 September, 2024

Bottomline: InvAscent-backed Malladi Drugs seeks to step up growth with potential IPO in sight

Malladi Drugs and Pharmaceuticals Ltd, which is backed by healthcare-focused private equity firm InvAscent, is seeking to accelerate business growth as ......

Premium

General

23 September, 2024

Grapevine: Nexus Select in talks to acquire mall; Anand Rathi, PhysicsWallah eye IPOs

Nexus Select Trust, backed by Blackstone, is in discussions to acquire Axis Mall in Kolkata, a media report said.   However, ......